Fibroblast growth factor 2 (FGF-2) is a novel substrate for arginine methylation by PRMT5

Biological Chemistry

Volumn 390, Issue 1, 2009, Pages 59-65

  Bruns, Alexander Francisco ^a,c   Grothe, Claudia ^a,b   Claus, Peter ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b CENTER FOR SYSTEMS NEUROSCIENCE   (Germany)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Basic FGF; Fibroblast growth factor; Nucleus; PRMT; Protein methyltransferase

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; PROTEIN ARGININE METHYLTRANSFERASE; RIBONUCLEOPROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; HUMAN; IN VITRO STUDY; METHYLATION; MOTONEURON; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

AMINO ACID SEQUENCE; ARGININE; CELL LINE; CELL NUCLEUS; ENZYME INHIBITORS; FIBROBLAST GROWTH FACTOR 2; HUMANS; METHYLATION; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN-ARGININE N-METHYLTRANSFERASE;

EID: 58249124384     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2009.001     Document Type: Article

References (42)

1. Bachand, F. (2007). Protein arginine methyltransferases: from unicellular eukaryotes to humans. Eukaryot. Cell 6, 889-898.
2. Bedford, M.T. (2007). Arginine methylation at a glance. J. Cell Sci. 120, 4243-4246.
3. Bedford, M.T., Frankel, A., Yaffe, M.B., Clarke, S., Leder, P., and Richard, S. (2000). Arginine methylation inhibits the binding of proline-rich ligands to Src homology 3, but not WW, domains. J. Biol. Chem. 275, 16030-16036.
4. Brahms, H., Raymackers, J., Union, A., de Keyser, F., Meheus, L., and Luhrmann, R. (2000). The C-terminal RG dipeptide repeats of the spliceosomal Sm proteins D1 and D3 contain symmetrical dimethylarginines, which form a major B-cell epitope for anti-Sm autoantibodies. J. Biol. Chem. 275, 17122-17129.
5. Brahms, H., Meheus, L., de Brabandere, V., Fischer, U., and Luhrmann, R. (2001). Symmetrical dimethylation of arginine residues in spliceosomal Sm protein B/B9 and the Sm-like protein LSm4, and their interaction with the SMN protein. RNA 7, 1531-1542.
6. Branscombe, T.L., Frankel, A., Lee, J.H., Cook, J.R., Yang, Z., Pestka, S., and Clarke, S. (2001). PRMT5 (Janus kinase-binding protein 1) catalyzes the formation of symmetric dimethyl-arginine residues in proteins. J. Biol. Chem. 276, 32971-32976.
7. Burgess, W.H., Bizik, J., Mehlman, T., Quarto, N., and Rifkin, D.B. (1991). Direct evidence for methylation of arginine residues in high molecular weight forms of basic fibroblast growth factor. Cell. Regul. 2, 87-93.
8. Chang, B., Chen, Y., Zhao, Y., and Bruick, R.K. (2007). JMJD6 is a histone arginine demethylase. Science 318, 444-447.
9. Claus, P., Doring, F., Gringel, S., Muller-Ostermeyer, F., Fuhlrott, J., Kraft, T., and Grothe, C. (2003). Differential intranuclear localization of fibroblast growth factor-2 isoforms and specific interaction with the survival of motoneuron protein. J. Biol. Chem. 278, 479-485.
10. 23 binds directly to the survival of motoneuron protein and is associated with small nuclear RNAs. Biochem. J. 384, 559-565.
11. Cote, J., Boisvert, F.M., Boulanger, M.C., Bedford, M.T., and Richard, S. (2003). Sam68 RNA binding protein is an in vivo substrate for protein arginine N-methyltransferase 1. Mol. Biol. Cell 14, 274-287.
12. Dono, R., James, D., and Zeller, R. (1998). A GR-motif functions in nuclear accumulation of the large FGF-2 isoforms and interferes with mitogenic signalling. Oncogene 16, 2151-2158.
13. Foletti, A., Vuadens, F., and Beermann, F. (2003). Nuclear localization of mouse fibroblast growth factor 2 requires N-terminal and C-terminal sequences. Cell. Mol. Life Sci. 60, 2254-2265.
14. Friesen, W.J. and Dreyfuss, G. (2000). Specific sequences of the Sm and Sm-like (Lsm) proteins mediate their interaction with the spinal muscular atrophy disease gene product (SMN). J. Biol. Chem. 275, 26370-26375.
15. Friesen, W.J., Massenet, S., Paushkin, S., Wyce, A., and Dreyfuss, G. (2001a). SMN, the product of the spinal muscular atrophy gene, binds preferentially to dimethylarginine-containing protein targets. Mol. Cell 7, 1111-1117.
16. Friesen, W.J., Paushkin, S., Wyce, A., Massenet, S., Pesiridis, G.S., Van Duyne, G., Rappsilber, J., Mann, M., and Dreyfuss, G. (2001b). The methylosome, a 20S complex containing JBP1 and pICln, produces dimethylarginine-modified Sm proteins. Mol. Cell. Biol. 21, 8289-8300.
17. Gremo, F. and Presta, M. (2000). Role of fibroblast growth factor-2 in human brain: a focus on development. Int. J. Dev. Neurosci. 18, 271-279.
18. Gringel, S., van Bergeijk, J., Haastert, K., Grothe, C., and Claus, P. (2004). Nuclear fibroblast growth factor-2 interacts specifically with splicing factor SF3a66. Biol. Chem. 385, 1203-1208.
19. Grothe, C. and Timmer, M. (2007). The physiological and pharmacological role of basic fibroblast growth factor in the dopaminergic nigrostriatal system. Brain Res. Rev. 54, 80-91.
20. Haastert, K., Lipokatic, E., Fischer, M., Timmer, M., and Grothe, C. (2006). Differentially promoted peripheral nerve regeneration by grafted Schwann cells over-expressing different FGF-2 isoforms. Neurobiol. Dis. 21, 138-153.
21. Herrmann, F., Lee, J., Bedford, M.T., and Fackelmayer, F.O. (2005). Dynamics of human protein arginine methyltransferase 1(PRMT1) in vivo. J. Biol. Chem. 280, 38005-38010.
22. Itoh, N. and Ornitz, D.M. (2004). Evolution of the Fgf and Fgfr gene families. Trends Genet. 20, 563-569.
23. Klein, S., Carroll, J.A., Chen, Y., Henry, M.F., Henry, P.A., Ortonowski, I.E., Pintucci, G., Beavis, R.C., Burgess, W.H., and Rifkin, D.B. (2000). Biochemical analysis of the arginine methylation of high molecular weight fibroblast growth factor-2. J. Biol. Chem. 275, 3150-3157.
24. Krause, C.D., Yang, Z.H., Kim, Y.S., Lee, J.H., Cook, J.R., and Pestka, S. (2007). Protein arginine methyltransferases: evolution and assessment of their pharmacological and therapeutic potential. Pharmacol. Ther. 113, 50-87.
25. Kwak, Y.T., Guo, J., Prajapati, S., Park, K.J., Surabhi, R.M., Miller, B., Gehrig, P., and Gaynor, R.B. (2003). Methylation of SPT5 regulates its interaction with RNA polymerase II and transcriptional elongation properties. Mol. Cell 11, 1055-1066.
26. Leadbeater, W.E., Gonzalez, A.M., Logaras, N., Berry, M., Turnbull, J.E., and Logan, A. (2006). Intracellular trafficking in neurons and glia of fibroblast growth factor-2, fibroblast growth factor receptor 1 and heparan sulphate proteoglycans in the injured adult rat cerebral cortex. J. Neurochem. 96, 1189-1200.
27. Liu, Q. and Dreyfuss, G. (1995). In vivo and in vitro arginine methylation of RNA-binding proteins. Mol. Cell. Biol. 15, 2800-2808.
28. Meister, G., Eggert, C., Buhler, D., Brahms, H., Kambach, C., and Fischer, U. (2001). Methylation of Sm proteins by a complex containing PRMT5 and the putative U snRNP assembly factor pICln. Curr. Biol. 11, 1990-1994.
29. Najbauer, J., Johnson, B.A., Young, A.L., and Aswad, D.W. (1993). Peptides with sequences similar to glycine, arginine-rich motifs in proteins interacting with RNA are efficiently recognized by methyltransferase(s) modifying arginine in numerous proteins. J. Biol. Chem. 268, 10501-10509.
30. Nichols, R.C., Wang, X.W., Tang, J., Hamilton, B.J., High, F.A., Herschman, H.R., and Rigby, W.F. (2000). The RGG domain in hnRNP A2 affects subcellular localization. Exp. Cell Res. 256, 522-532.
31. Nishioka, K. and Reinberg, D. (2003). Methods and tips for the purification of human histone methyltransferases. Methods 31, 49-58.
32. Pal, S., Vishwanath, S.N., Erdjument-Bromage, H., Tempst, P., and Sif, S. (2004). Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes. Mol. Cell. Biol. 24, 9630-9645.
33. Pintucci, G., Quarto, N., and Rifkin, D.B. (1996). Methylation of high molecular weight fibroblast growth factor-2 determines post-translational increases in molecular weight and affects its intracellular distribution. Mol. Biol. Cell 7, 1249-1258.
34. Pollack, B.P., Kotenko, S.V., He, W., Izotova, L.S., Barnoski, B.L., and Pestka, S. (1999). The human homologue of the yeast proteins Skb1 and Hsl7p interacts with Jak kinases and contains protein methyltransferase activity. J. Biol. Chem. 274, 31531-31542.
35. 2-terminal extension of high molecular weight bFGF is a nuclear targeting signal. J. Cell Physiol. 147, 311-318.
36. Rho, J., Choi, S., Seong, Y.R., Cho, W.K., Kim, S.H., and Im, D.S. (2001). Prmt5, which forms distinct homo-oligomers, is a member of the protein-arginine methyltransferase family. J. Biol. Chem. 276, 11393-11401.
37. Sheng, Z., Lewis, J.A., and Chirico, W.J. (2004). Nuclear and nucleolar localization of 18-kDa fibroblast growth factor-2 is controlled by C-terminal signals. J. Biol. Chem. 279, 40153-40160.
38. Sommer, A., Moscatelli, D., and Rifkin, D.B. (1989). An amino-terminally extended and post-translationally modified form of a 25 kD basic fibroblast growth factor. Biochem. Biophys. Res. Commun. 160, 1267-1274.
39. Sorensen, V., Nilsen, T., and Wiedlocha, A. (2006). Functional diversity of FGF-2 isoforms by intracellular sorting. Bioessays 28, 504-514.
40. Teng, Y., Girvan, A.C., Casson, L.K., Pierce, W.M. Jr., Qian, M., Thomas, S.D., and Bates, P.J. (2007). AS1411 alters the localization of a complex containing protein arginine methyltransferase 5 and nucleolin. Cancer Res. 67, 10491-10500.
41. Timmer, M., Cesnulevicius, K., Winkler, C., Kolb, J., Lipokatic-Takacs, E., Jungnickel, J., and Grothe, C. (2007). Fibroblast growth factor (FGF)-2 and FGF receptor 3 are required for the development of the substantia nigra, and FGF-2 plays a crucial role for the rescue of dopaminergic neurons after 6-hydroxydopamine lesion. J. Neurosci. 27, 459-471.
42. Yu, P.J., Ferrari, G., Pirelli, L., Galloway, A.C., Mignatti, P., and Pintucci, G. (2008). Thrombin cleaves the high molecular weight forms of basic fibroblast growth factor (FGF-2): a novel mechanism for the control of FGF-2 and thrombin activity. Oncogene 27, 2594-2601.